EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lomerizine Suppresses JAK2/STAT3 Pathway Activation via CACNA1B in HNSCC

Yashu Liu, Zihui Zhang, Yan Zhao, Chaoge Liu, Yutian Cai, Xiaoting Gu, Yingbin Yan, Honggang Zhou, Ting Xiao

Molecules · 11.11.2026 · 31 (22) · 4052

DOI: 10.3390/molecules31224052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 11.11.2026. Verfasst von Yashu Liu und 8 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stomatology Institute of Nankai University, National Natural Science Foundation of China, Natural Science Foundation of Tianjin.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The JAK2/STAT3 pathway contributes to head and neck squamous cell carcinoma (HNSCC) progression. Using a STAT3 reporter assay, we screened a panel of 79 compounds and identified lomerizine, a calcium channel blocker approved in Japan for migraine prophylaxis, as an inhibitor of reporter activity. Lomerizine reduced JAK2 and STAT3 phosphorylation in CAL-27 cells and suppressed proliferation in the HNSCC cell models tested. Ferroptosis-associated readouts and EMT-marker changes were observed in CAL-27 HNSCC cells. In cisplatin-resistant CAL-27-DDP cells, combined lomerizine and cisplatin treatment reduced cell viability compared with cisplatin alone. Target prediction, molecular docking, cellular thermal shift assay (CETSA), and CACNA1B knockdown results implicate CACNA1B as a candidate mediator of lomerizine-associated JAK2/STAT3 changes. Lomerizine treatment also reduced tumor growth in PDX and CAL-27 xenograft models. These findings support further preclinical evaluation of lomerizine in HNSCC.

Förderung

  • Stomatology Institute of Nankai University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin
  • Foundation of Organ Fibrosis Drug Ability Joint Research Centre of Nankai and Guokaixingcheng
  • 111 Project

Zitieren

APA

Liu, Y., Zhang, Z., Zhao, Y., Liu, C., Cai, Y., Gu, X., Yan, Y., Zhou, H., & Xiao, T. (2026). Lomerizine Suppresses JAK2/STAT3 Pathway Activation via CACNA1B in HNSCC. Molecules, 31(22), 4052. https://doi.org/10.3390/molecules31224052

Vancouver

Liu Y, Zhang Z, Zhao Y, Liu C, Cai Y, Gu X, et al. Lomerizine Suppresses JAK2/STAT3 Pathway Activation via CACNA1B in HNSCC. Molecules. 2026;31(22):4052. doi:10.3390/molecules31224052

BibTeX
@article{Liu2026,
  author = {Liu, Yashu and Zhang, Zihui and Zhao, Yan and Liu, Chaoge and Cai, Yutian and Gu, Xiaoting and Yan, Yingbin and Zhou, Honggang and Xiao, Ting},
  title = {Lomerizine Suppresses JAK2/STAT3 Pathway Activation via CACNA1B in HNSCC},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {22},
  pages = {4052},
  doi = {10.3390/molecules31224052}
}
Kostenlos starten →